Tobacco use across the formative years: a road map to developmental vulnerabilities.
Different vulnerabilities are launched or play a more active role at different developmental stages and different ages. Furthermore, the interplay between developmental and biological, psychosocial, and environmental vulnerabilities is expected to differ across stages of smoking. This article focuses on the intersection of vulnerability associated with adolescence with tobacco-use vulnerability resulting from biological, psychological, and environmental characteristics of an adolescent. Recommendations include the following: (a) Effectively treat childhood and adolescent behavioral and emotional disorders that place adolescents at risk; (b) target programs toward specific high-risk subgroups; (c) incorporate training in self-control, affect regulation, and healthy coping strategies into educational programs and extracurricular activities; (d) encourage youth to develop healthy sources of success and satisfaction; (e) encourage communities and states to launch environmental, policy, and regulatory initiatives to protect youth from tobacco; (f) consider bold initiatives that will require fundamental changes in public attitudes, including monetary rewards for nonsmoking, heightened penalties for facilitating and engaging in underage smoking, and government subsidies for substitute pharmacological agents.
Jamner
Larry D
LD
Department of Pharmacology University of California Irvine, 92697-7085, USA. ljammer@uci.edu
Whalen
Carol K
CK
Loughlin
Sandra E
SE
Mermelstein
Robin
R
Audrain-McGovern
Janet
J
Krishnan-Sarin
Suchitra
S
Worden
John K
JK
Leslie
Frances M
FM
D000223:Adaptation, Psychological; D000293:Adolescent / Q000502:physiology; D000294:Adolescent Behavior; D000342:Affective Symptoms; D002648:Child; D002652:Child Behavior; D005260:Female; D006801:Humans; D007389:Internal-External Control; D008297:Male; D011639:Public Opinion; D011640:Public Policy; D012307:Risk Factors; D012907:Smoking / Q000523:psychology*; D016540:Smoking Cessation; D014029:Tobacco Use Disorder / Q000503:physiopathology* / Q000523:psychology*